| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | beta-adrenergic receptor kinase activity | 4.62e-05 | 4 | 56 | 2 | GO:0047696 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor kinase activity | 1.61e-04 | 7 | 56 | 2 | GO:0004703 | |
| GeneOntologyMolecularFunction | opioid receptor binding | 2.75e-04 | 9 | 56 | 2 | GO:0031628 | |
| GeneOntologyMolecularFunction | protein kinase A binding | 5.78e-04 | 58 | 56 | 3 | GO:0051018 | |
| Domain | GPCR_kinase | 1.97e-04 | 7 | 58 | 2 | IPR000239 | |
| Domain | AAA | 5.64e-04 | 52 | 58 | 3 | PF00004 | |
| Domain | TPR_8 | 5.96e-04 | 53 | 58 | 3 | PF13181 | |
| Domain | ATPase_AAA_core | 6.30e-04 | 54 | 58 | 3 | IPR003959 | |
| Domain | AAA+_ATPase | 1.04e-03 | 144 | 58 | 4 | IPR003593 | |
| Domain | AAA | 1.04e-03 | 144 | 58 | 4 | SM00382 | |
| Domain | ATPase_AAA_CS | 3.65e-03 | 29 | 58 | 2 | IPR003960 | |
| Domain | - | 3.90e-03 | 207 | 58 | 4 | 1.25.40.10 | |
| Domain | AAA | 4.99e-03 | 34 | 58 | 2 | PS00674 | |
| Domain | RGS | 5.28e-03 | 35 | 58 | 2 | PF00615 | |
| Domain | RGS | 5.28e-03 | 35 | 58 | 2 | SM00315 | |
| Domain | RGS | 5.58e-03 | 36 | 58 | 2 | PS50132 | |
| Domain | TPR-like_helical_dom | 5.91e-03 | 233 | 58 | 4 | IPR011990 | |
| Domain | Protein_kinase_ATP_BS | 6.36e-03 | 379 | 58 | 5 | IPR017441 | |
| Domain | RGS | 6.52e-03 | 39 | 58 | 2 | IPR016137 | |
| Domain | Kinase-like_dom | 6.56e-03 | 542 | 58 | 6 | IPR011009 | |
| Domain | - | 6.85e-03 | 40 | 58 | 2 | 4.10.1000.10 | |
| Domain | TPR | 7.53e-03 | 129 | 58 | 3 | SM00028 | |
| Domain | Rossmann-like_a/b/a_fold | 7.89e-03 | 43 | 58 | 2 | IPR014729 | |
| Domain | - | 7.89e-03 | 43 | 58 | 2 | 3.40.50.620 | |
| Domain | TPR_repeat | 8.19e-03 | 133 | 58 | 3 | IPR019734 | |
| Pubmed | 5.52e-07 | 10 | 59 | 3 | 1869533 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 8638670 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 33060647 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 8035170 | ||
| Pubmed | Altered airway and cardiac responses in mice lacking G protein-coupled receptor kinase 3. | 2.83e-06 | 2 | 59 | 2 | 10198406 | |
| Pubmed | G-protein coupled receptor kinase 2 and 3 expression in human detrusor cultured smooth muscle cells. | 2.83e-06 | 2 | 59 | 2 | 11762794 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 20477813 | ||
| Pubmed | An adenylyl cyclase-mAKAPbeta signaling complex regulates cAMP levels in cardiac myocytes. | 2.83e-06 | 2 | 59 | 2 | 19574217 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 10754297 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 10085131 | ||
| Pubmed | Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. | 8.48e-06 | 3 | 59 | 2 | 7761854 | |
| Pubmed | The N-termini of GRK2 and GRK3 simulate the stimulating effects of RKIP on β-adrenoceptors. | 8.48e-06 | 3 | 59 | 2 | 31604529 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 12130708 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 9847314 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 12589057 | ||
| Pubmed | The nuclear pore complex: a new dynamic in HIV-1 replication. | 8.48e-06 | 3 | 59 | 2 | 21327100 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 8943370 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 20385770 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 24913231 | ||
| Pubmed | 1.67e-05 | 1116 | 59 | 10 | 31753913 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 21784156 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 9368759 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 20861915 | ||
| Pubmed | Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. | 1.69e-05 | 4 | 59 | 2 | 8917529 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 8662816 | ||
| Pubmed | Hierarchical organization of multi-site phosphorylation at the CXCR4 C terminus. | 1.69e-05 | 4 | 59 | 2 | 23734232 | |
| Pubmed | In vitro analysis of nuclear transport mediated by the C-terminal shuttle domain of Tap. | 1.69e-05 | 4 | 59 | 2 | 11551912 | |
| Pubmed | Biallelic mutations in nucleoporin NUP88 cause lethal fetal akinesia deformation sequence. | 1.69e-05 | 4 | 59 | 2 | 30543681 | |
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 10338466 | ||
| Pubmed | DOCK2 mediates T cell receptor-induced activation of Rac2 and IL-2 transcription. | 2.82e-05 | 5 | 59 | 2 | 12176041 | |
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 19828735 | ||
| Pubmed | NELL2-mediated lumicrine signaling through OVCH2 is required for male fertility. | 2.82e-05 | 5 | 59 | 2 | 32499443 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | KNTC1 GANAB JMJD6 NPEPPS NUP98 LARS1 STK39 GMPR2 RFC3 PHAX LRRFIP1 | 2.91e-05 | 1455 | 59 | 11 | 22863883 |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 9826657 | ||
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 20074556 | ||
| Pubmed | Karyopherin beta2 mediates nuclear import of a mRNA binding protein. | 4.23e-05 | 6 | 59 | 2 | 9144189 | |
| Pubmed | Cessation of HIV-1 transcription by inhibiting regulatory protein Rev-mediated RNA transport. | 4.23e-05 | 6 | 59 | 2 | 19149559 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 36451830 | ||
| Pubmed | Synaptic, transcriptional and chromatin genes disrupted in autism. | 5.91e-05 | 7 | 59 | 2 | 25363760 | |
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 11238447 | ||
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 8672451 | ||
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 11517230 | ||
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 23039116 | ||
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 7.87e-05 | 8 | 59 | 2 | 12634303 | |
| Pubmed | Imaging within single NPCs reveals NXF1's role in mRNA export on the cytoplasmic side of the pore. | 7.87e-05 | 8 | 59 | 2 | 31375530 | |
| Pubmed | 7.88e-05 | 613 | 59 | 7 | 22268729 | ||
| Pubmed | 1.01e-04 | 9 | 59 | 2 | 34873237 | ||
| Pubmed | 1.01e-04 | 9 | 59 | 2 | 9114010 | ||
| Pubmed | 1.22e-04 | 284 | 59 | 5 | 29459677 | ||
| Pubmed | 1.26e-04 | 10 | 59 | 2 | 19581287 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 1.30e-04 | 1425 | 59 | 10 | 30948266 | |
| Pubmed | 1.52e-04 | 916 | 59 | 8 | 32203420 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 1.57e-04 | 477 | 59 | 6 | 31300519 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 1.84e-04 | 942 | 59 | 8 | 31073040 | |
| Pubmed | 2.38e-04 | 1247 | 59 | 9 | 27684187 | ||
| Pubmed | 2.52e-04 | 332 | 59 | 5 | 25693804 | ||
| Pubmed | MEIOB targets single-strand DNA and is necessary for meiotic recombination. | 2.54e-04 | 14 | 59 | 2 | 24068956 | |
| Pubmed | 2.54e-04 | 14 | 59 | 2 | 11073998 | ||
| Pubmed | Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. | 2.54e-04 | 14 | 59 | 2 | 28263302 | |
| Pubmed | 2.81e-04 | 754 | 59 | 7 | 35906200 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 2.85e-04 | 533 | 59 | 6 | 30554943 | |
| Pubmed | HORMAD1-dependent checkpoint/surveillance mechanism eliminates asynaptic oocytes. | 2.93e-04 | 15 | 59 | 2 | 22530760 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 3.22e-04 | 1024 | 59 | 8 | 24711643 | |
| Pubmed | An approach based on a genome-wide association study reveals candidate loci for narcolepsy. | 3.30e-04 | 193 | 59 | 4 | 20677014 | |
| Pubmed | 3.34e-04 | 16 | 59 | 2 | 9417904 | ||
| Pubmed | RUNX1 Familial Platelet Disorder with Associated Myeloid Malignancies | 3.79e-04 | 17 | 59 | 2 | 33661592 | |
| Pubmed | 3.79e-04 | 17 | 59 | 2 | 10668806 | ||
| Pubmed | 3.79e-04 | 17 | 59 | 2 | 20963938 | ||
| Pubmed | 3.79e-04 | 17 | 59 | 2 | 33226740 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.92e-04 | 202 | 59 | 4 | 33005030 | |
| Pubmed | DDX41-Associated Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia | 4.25e-04 | 18 | 59 | 2 | 34723452 | |
| Pubmed | 4.57e-04 | 378 | 59 | 5 | 34315543 | ||
| Pubmed | 6.29e-04 | 98 | 59 | 3 | 19554387 | ||
| Pubmed | 6.39e-04 | 22 | 59 | 2 | 25331947 | ||
| Pubmed | 6.41e-04 | 1429 | 59 | 9 | 35140242 | ||
| Pubmed | 6.48e-04 | 1431 | 59 | 9 | 37142655 | ||
| Pubmed | 6.77e-04 | 1440 | 59 | 9 | 30833792 | ||
| Pubmed | 6.87e-04 | 101 | 59 | 3 | 26949739 | ||
| Pubmed | 7.13e-04 | 237 | 59 | 4 | 29564676 | ||
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | 7.51e-04 | 422 | 59 | 5 | 27342126 | |
| Pubmed | 8.10e-04 | 650 | 59 | 6 | 38777146 | ||
| Pubmed | 8.28e-04 | 25 | 59 | 2 | 10601273 | ||
| Pubmed | 8.29e-04 | 653 | 59 | 6 | 33742100 | ||
| Pubmed | 8.78e-04 | 437 | 59 | 5 | 20562859 | ||
| Pubmed | 8.96e-04 | 26 | 59 | 2 | 12228227 | ||
| Pubmed | Modulation of HIV pathogenesis and T-cell signaling by HIV-1 Nef. | 9.66e-04 | 27 | 59 | 2 | 22844345 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 1.27e-03 | 974 | 59 | 7 | 28675297 | |
| Pubmed | BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs. | 1.27e-03 | 31 | 59 | 2 | 23086144 | |
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | 1.37e-03 | 283 | 59 | 4 | 18854154 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | 1.41e-03 | 1284 | 59 | 8 | 17353931 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 1.48e-03 | 1294 | 59 | 8 | 30804502 | |
| Pubmed | Identification of 14-3-3epsilon substrates from embryonic murine brain. | 1.49e-03 | 132 | 59 | 3 | 16944949 | |
| Pubmed | 1.50e-03 | 493 | 59 | 5 | 15368895 | ||
| Pubmed | 1.51e-03 | 494 | 59 | 5 | 26831064 | ||
| Pubmed | 1.52e-03 | 133 | 59 | 3 | 15144186 | ||
| Pubmed | Nuclear pore composition regulates neural stem/progenitor cell differentiation in the mouse embryo. | 1.53e-03 | 34 | 59 | 2 | 18539113 | |
| Pubmed | Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. | 1.53e-03 | 34 | 59 | 2 | 12791985 | |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 1.59e-03 | 135 | 59 | 3 | 31077711 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 1.66e-03 | 1318 | 59 | 8 | 30463901 | |
| Cytoband | 2q24.3 | 1.93e-04 | 16 | 59 | 2 | 2q24.3 | |
| Cytoband | 12q15 | 7.86e-04 | 32 | 59 | 2 | 12q15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p13 | 1.49e-03 | 174 | 59 | 3 | chr9p13 | |
| Cytoband | 14q12 | 2.31e-03 | 55 | 59 | 2 | 14q12 | |
| GeneFamily | AAA ATPases | 2.02e-04 | 53 | 39 | 3 | 413 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 1.77e-03 | 29 | 39 | 2 | 396 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.94e-03 | 115 | 39 | 3 | 769 | |
| GeneFamily | Nucleoporins | 2.16e-03 | 32 | 39 | 2 | 1051 | |
| GeneFamily | Ankyrin repeat domain containing | 1.52e-02 | 242 | 39 | 3 | 403 | |
| ToppCell | RV-17._Lymphocyte|RV / Chamber and Cluster_Paper | 1.84e-06 | 153 | 59 | 5 | e1ea621184014415870e00d511386b8cc3e0833b | |
| ToppCell | RV-17._Lymphocyte|World / Chamber and Cluster_Paper | 1.96e-06 | 155 | 59 | 5 | 189276a3b400b2202e6681e23732e6452bfe704e | |
| ToppCell | LA-17._Lymphocyte|World / Chamber and Cluster_Paper | 3.86e-06 | 178 | 59 | 5 | 34ec499d03cc198cfefa19a724d4c81974052f65 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.96e-06 | 179 | 59 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Mesenchymal_cells-Stromal_fibro.|Mesenchymal_cells / Lineage and Cell class | 4.19e-06 | 181 | 59 | 5 | f8d914fdc06aaa75a4dc9158daf574ca28fa5432 | |
| ToppCell | LA-17._Lymphocyte|LA / Chamber and Cluster_Paper | 4.19e-06 | 181 | 59 | 5 | 3fd9f805fa46141b0fa7023ee5d8688d338635d5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.87e-06 | 194 | 59 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Interneuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.02e-05 | 121 | 59 | 4 | b2d571f571133c281d72584fe925cebbd2317829 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.56e-05 | 149 | 59 | 4 | 65778f19599b4955c0a16f0121237656449431fb | |
| ToppCell | IPF-Epithelial-Ionocyte|Epithelial / Disease state, Lineage and Cell class | 5.73e-05 | 158 | 59 | 4 | 67adf625a959444762d32268b3b7441f6f8b3b8c | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-05 | 163 | 59 | 4 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-05 | 163 | 59 | 4 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 165 | 59 | 4 | 1703d3eb644b3c743ad3c5532b1d29ea010c79c8 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.61e-05 | 170 | 59 | 4 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Mast_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.79e-05 | 171 | 59 | 4 | ac37c80c832504986c7a201d84f4b6aff5e5f323 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.79e-05 | 171 | 59 | 4 | b6502a81df4f25660f3ae4b7443a1d999df2d32b | |
| ToppCell | LV-17._Lymphocyte|World / Chamber and Cluster_Paper | 8.15e-05 | 173 | 59 | 4 | 212f013ff761cbab24a537071739867c08c402a4 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.90e-05 | 177 | 59 | 4 | 6d89042bda8e244babb68929e84b25edcb545a77 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.90e-05 | 177 | 59 | 4 | daaccf1249dcf816df4caca695a944f53078291a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.90e-05 | 177 | 59 | 4 | 338bdda26796bf4e16072878c070212d1006cf57 | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.90e-05 | 177 | 59 | 4 | b5c20c1247f11ebc97e9cb47482564cd74e36ca6 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.90e-05 | 177 | 59 | 4 | c5a16f984c836dbf7d0faf061677844167ab612a | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-basal_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 9.10e-05 | 178 | 59 | 4 | 03f22485074b3cbf9a6ad4d543c5bbfa826dc741 | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.29e-05 | 179 | 59 | 4 | de3ddc1264e43727be50d69b81cc84a3c91812a2 | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.29e-05 | 179 | 59 | 4 | def981e97e3ff9019910c9af3861ca0d08eb0d0f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-05 | 180 | 59 | 4 | be10fe5bf7c3a671c42704ce7dd8226ab6896794 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.50e-05 | 180 | 59 | 4 | a999a6d219a8e58a8b63802ddf8c95ffaab9cfa0 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-05 | 180 | 59 | 4 | 3b747a517ce75ef2ff09011c037dad7b01ed3e03 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | 9.70e-05 | 181 | 59 | 4 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 | |
| ToppCell | LV-17._Lymphocyte|LV / Chamber and Cluster_Paper | 9.70e-05 | 181 | 59 | 4 | 81fafa69c8c240250a667a5f3b321e8be1b9a288 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 9.70e-05 | 181 | 59 | 4 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 183 | 59 | 4 | a97f052950429245c3231464271e1ba539863bba | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.06e-04 | 185 | 59 | 4 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 185 | 59 | 4 | 554c5d812197fbf66bf279fcc953277e926ade15 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 186 | 59 | 4 | 61de94c9ba90e7b6780694199c059c798b1488ae | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 187 | 59 | 4 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 187 | 59 | 4 | 150023e6a50c9da461f2321074d2d5e96caafb06 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 187 | 59 | 4 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 187 | 59 | 4 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.10e-04 | 187 | 59 | 4 | f31d865ce2a21bdf64dbe29ee3e4505ab482604a | |
| ToppCell | LPS_only-Lymphocytic_NKT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-04 | 188 | 59 | 4 | bbe65b1c11c88ab62d8485cfc3a913ff9da89aad | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 189 | 59 | 4 | 4dc32b463546bbe7250dddd281b92ad17ec22da1 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 189 | 59 | 4 | 0d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f | |
| ToppCell | PSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.19e-04 | 191 | 59 | 4 | 8f4637e801554e2343b974fe7794f01dd2151418 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.19e-04 | 191 | 59 | 4 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-04 | 191 | 59 | 4 | 468b5149d1533f03521844d3cce8633d44eb6ed4 | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.19e-04 | 191 | 59 | 4 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-04 | 192 | 59 | 4 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-04 | 192 | 59 | 4 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-04 | 192 | 59 | 4 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.24e-04 | 193 | 59 | 4 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.24e-04 | 193 | 59 | 4 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-04 | 194 | 59 | 4 | ea5b7727ffef6cb454c501979a51bc1d4108d0e4 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.29e-04 | 195 | 59 | 4 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_neuro-secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-04 | 196 | 59 | 4 | a4cc02ea41479d24044bd2ca6441f85d683c0ca9 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.32e-04 | 196 | 59 | 4 | 541b1fcf509e362f6f48720046cb5378aaf7c591 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-04 | 196 | 59 | 4 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.34e-04 | 197 | 59 | 4 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 1.34e-04 | 197 | 59 | 4 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.34e-04 | 197 | 59 | 4 | f7ef62d78336812573148f8bfce401877ec4e29c | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-Trm_Th1/Th17|GI_small-bowel / Manually curated celltypes from each tissue | 1.37e-04 | 198 | 59 | 4 | f4fc0cac858fc6dcd779d7959ccec51f78ea8cc2 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_monocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.37e-04 | 198 | 59 | 4 | 100091c91fde604daf110f20b44505f240f93ae8 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Lymphocytic-Lymphocytic_NK/T|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.37e-04 | 198 | 59 | 4 | a07590c6aa2c889b5d1a0413a6fba5b75bf5d70a | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_monocytic-monocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.37e-04 | 198 | 59 | 4 | 73e9ada6998c09ae3a3a66e920b28694b7f9cf6b | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-04 | 198 | 59 | 4 | 7608f67959e1cda7b10e57fd3af2f96216ebe7e9 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.40e-04 | 199 | 59 | 4 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.42e-04 | 200 | 59 | 4 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.42e-04 | 200 | 59 | 4 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.42e-04 | 200 | 59 | 4 | 3d932765c31aef1f80a118d51e8e66c50a758dbb | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.42e-04 | 200 | 59 | 4 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| Drug | benzeneacetamide | 6.12e-06 | 46 | 59 | 4 | CID000007680 | |
| Drug | PDEs | 1.27e-05 | 116 | 59 | 5 | CID003036959 | |
| Drug | Glafenine hydrochloride [65513-72-6]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.27e-05 | 199 | 59 | 6 | 7418_UP | |
| Disease | Parkinson's disease (biomarker_via_orthology) | 2.53e-05 | 30 | 56 | 3 | DOID:14330 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of breast | AKAP6 SLC8A3 JMJD6 NUP98 NUP214 HADHB KIT FAAH LRRFIP1 SORL1 | 3.04e-05 | 1074 | 56 | 10 | C0006142 |
| Disease | apolipoprotein A 1 measurement | 1.89e-04 | 848 | 56 | 8 | EFO_0004614 | |
| Disease | PR interval | 3.45e-04 | 495 | 56 | 6 | EFO_0004462 | |
| Disease | Cannabis Dependence | 4.72e-04 | 17 | 56 | 2 | C0006870 | |
| Disease | Acute myeloid leukemia | 4.72e-04 | 17 | 56 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 4.72e-04 | 17 | 56 | 2 | 601626 | |
| Disease | congestive heart failure (is_marker_for) | 5.16e-04 | 82 | 56 | 3 | DOID:6000 (is_marker_for) | |
| Disease | Chronic myeloproliferative disorder | 5.93e-04 | 19 | 56 | 2 | C1292778 | |
| Disease | Marijuana Abuse | 1.49e-03 | 30 | 56 | 2 | C0024809 | |
| Disease | Acute Myeloid Leukemia, M1 | 1.75e-03 | 125 | 56 | 3 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.75e-03 | 125 | 56 | 3 | C1879321 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YGCRKADTGKMYAMK | 206 | P35626 | |
| ADTGKMYAMKCLDKK | 211 | P35626 | |
| SYGKKKDAMYGNFML | 316 | Q8IVF6 | |
| KDAMYGNFMLKKDIA | 321 | Q8IVF6 | |
| GSAVILGMEKAYKMK | 1611 | Q68DQ2 | |
| LGMEKAYKMKDTEGD | 1616 | Q68DQ2 | |
| MEKLKDKAGYMSGML | 701 | Q86TY3 | |
| YGKKKDEMFGNFMLK | 326 | A2A2Z9 | |
| GGNKKLIYFIDDMNM | 2566 | Q96DT5 | |
| VKVKGKGEMMTYFLN | 1241 | O95622 | |
| SLIFLMKDYMGRGKI | 111 | O15519 | |
| MAEEKALAMGYKPKA | 321 | P55084 | |
| YGCRKADTGKMYAMK | 206 | P25098 | |
| ADTGKMYAMKCLDKK | 211 | P25098 | |
| GHDLKDMMLYCKFKG | 161 | Q16515 | |
| MGLKKMKGLSYDEAF | 1 | Q96QF0 | |
| GGFMKRYGGFMKKMD | 101 | P01210 | |
| LKRKAFYMAGQGDMD | 316 | Q5HY92 | |
| EKSVTYGKGKLLMDM | 1121 | P52948 | |
| CGEDNDGYSVKMKMK | 101 | Q6NYC1 | |
| KYMGKGSMTGLALKH | 726 | O00339 | |
| MPMYKSGDLVFAKLK | 6 | Q5TGJ6 | |
| AKMFKLDTGKMPVVY | 456 | Q8IWI9 | |
| DSKFYKMIKEGFRML | 876 | P10721 | |
| MLKKEYMESFEGIFK | 516 | Q9HCG8 | |
| MMGYHKGELLGKELA | 301 | O95263 | |
| EMKDKGGYMSKICNL | 331 | Q9NST1 | |
| YHKLLKDAGGMVIDM | 141 | P35658 | |
| SYKLMEMKKLLRGYG | 836 | P50748 | |
| KKYKLFYGMSSEMAM | 261 | Q9P2T1 | |
| LFFMYGKPKSKDSMG | 256 | Q9NQN1 | |
| YIGDKDFKKGMNMYL | 451 | A6NEC2 | |
| KISLKGSDGKFYIMM | 2311 | Q13535 | |
| GSDGKFYIMMCKPKD | 2316 | Q13535 | |
| LGKYDVKQMGTKYML | 281 | Q8N9C0 | |
| DKGEKNFAMSYVKLM | 521 | Q92608 | |
| MMEKYEKIGKIGEGS | 1 | Q00532 | |
| KDKMAEAYSEIGMKG | 116 | P20963 | |
| SGKMKEKRYDASKGM | 931 | Q6P158 | |
| YAAMKKKIYAMGGGS | 416 | Q9H2C0 | |
| YFGDIWDKMLQKGMK | 526 | O00519 | |
| YKKLHSYGRDQKGMM | 196 | O43933 | |
| YIGDKDFKKGMNMYL | 451 | P55786 | |
| GKYMQGLKEMKDSLA | 151 | Q32MZ4 | |
| LMDMLFIKGKYKSAL | 171 | Q8WV60 | |
| LDKELDEYMHGGKKM | 171 | Q9H814 | |
| DEYMHGGKKMGSKEE | 176 | Q9H814 | |
| VAKFMALYKKFMEDG | 336 | P40938 | |
| ALYKKFMEDGLEGMM | 341 | P40938 | |
| LTGLMDMKIFYKGKN | 1001 | Q92673 | |
| NYEKMMFKEALKTGF | 811 | Q9P2J5 | |
| KKPMDYDIALLKMAG | 136 | Q7RTZ1 | |
| GKTLFGKMMDYLQGS | 331 | Q14697 | |
| GHYKFGMSKKEMEQV | 581 | O43147 | |
| VGFMLYRMKKKDEGS | 271 | P18827 | |
| KLMEEGDMFYKKGKV | 1246 | Q9HCD6 | |
| MMFKEAKFKMGYADE | 196 | P50452 | |
| SSMPLAGMKKYADEK | 726 | Q13023 | |
| GMKLMYKGEDGKAVA | 236 | Q02040 | |
| VEMLAKKFEMKYGGK | 176 | Q6ZU65 | |
| MGEGNMLYKSIKKEL | 451 | Q13064 | |
| KGKYMYFTVVMAEGK | 246 | Q8WV24 | |
| DTKDVLGLMGKAMYF | 176 | Q8NDW8 | |
| GYFNLGMLAMDDKKD | 671 | Q6ZXV5 | |
| GVEDKEMMKKYGKSF | 296 | Q9UEW8 | |
| KGGDMSKTMYVDYKT | 421 | P57103 | |
| KVAKMGPYSMFCKLL | 606 | Q6IA69 |